LONDON, July 15 (Reuters) - Simon Lowth, the chief financial officer of AstraZeneca, is to leave the pharmaceutical firm to take over the same role at oil and gas firm BG Group, the two companies ...

The Board's decision to appoint Simon Lowth as interim Chief Executive Officer has my full support and I am confident that AstraZeneca will continue to have a positive impact on the lives of ...

Pascal Soriot will take on his new responsibilities and join the AstraZeneca PLC Board as an Executive Director on 1 October 2012. Simon Lowth will remain as AstraZeneca's Interim Chief Executive ...

AstraZeneca today announced that Marc Dunoyer has been appointed Chief Financial Officer and will join the company Board as an Executive Director. He succeeds Simon Lowth who leaves AstraZeneca ...

Simon Lowth, who was finance director of BG Group ... He has been CFO of, and served on the boards of, BG Group, drugmaker AstraZeneca and utility group ScottishPower in the last 11 years.

The interest of Simon Lowth, a Director of the Company, in AstraZeneca PLC ordinary shares, has changed as detailed below. On 7 May 2013, Mr Lowth received shares from the vesting of a previously ...

Simon Lowth, will join the board as independent non-executive director on January 1. Prior to BT, Lowth was CFO of BG Group - now part of Shell PLC - AstraZeneca PLC, and Scottish Power.